Seeking Alpha
View as an RSS Feed

Bret Jensen  

View Bret Jensen's Articles BY TICKER:
A, AA, AAPL, AAWW, ABB, ABBV, ABT, ABTL, ABX, ACET, ACLS, ACMP, ACTG, ACTV, ADBE, ADSK, AEP, AER, AGCO, AGEN, AGU, AHH, AHT, AIG, AKS, ALJ, ALL, ALR, AMAT, AMFW, AMGN, AMKR, AMTD, AMZG, AMZN, ANF, ANIK, ANV, APA, APC, APEI, APL, ARCP, ARII, ARLP, ARO, ARP, ASH, ATRS, ATSG, ATU, ATVI, ATW, AU, AVGO, AVNR, AXAS, AXTI, AYR, AZN, BA, BAC, BAS, BAX, BBBY, BBEP, BBRY, BBT, BBW, BBY, BCEI, BGC, BGFV, BHI, BIDU, BIG, BIIB, BIOL, BK, BKCC, BKH, BLK, BMO, BMR, BNS, BP, BRCD, BRCM, BRKS, BTU, BWP, BX, BYI, C, CALL, CARB, CAT, CBI, CBOU, CDE, CELG, CEO, CERS, CGIX, CGR, CHK, CHKP, CHL, CHMT, CJES, CKSW, CLDT, CLF, CLMT, CLR, CMG, CMI, CMLP, CNAT, CNDO, CNP, CNQ, CNQR, CNX, COF, COG, COH, COOL, COP, CORT, COV, CPE, CPIX, CPNO, CPSI, CRM, CROX, CRUS, CRZO, CSCO, CSX, CTCM, CVE, CVS, CVX, CXPO, CXS, CY, DAKT, DAN, DD, DDE, DE, DECK, DELL, DENN, DG, DIS, DK, DNR, DO, DOW, DPM, DRH, DRIV, DSCO, DTLK, DTV, DUSA, DVAX, DVN, DVR, DWA, DXLG, DY, E, EBAY, ECA, ECPG, ECYT, EDR, ELY, EMC, END, ENDP, EOG, EOX, EPAM, EPAX, EPB, EPD, EPIQ, EPR, EQM, EROC, ESIO, ESV, ETE, ETN, ETP, ETRM, EVEP, EWZ, EXK, EXLP, EXXI, F, FANG, FB, FCH, FCX, FDX, FIG, FLL, FLR, FLY, FOLD, FOSL, FRD, FSC, FSII, FST, FURX, FXCM, GA, GBX, GCOM, GD, GE, GEF, GEL, GEOY, GERN, GES, GEVA, GFI, GILD, GLP, GLUU, GLW, GM, GNMK, GNW, GOLD, GOOG, GOOGL, GPOR, GPS, GS, GSK, GSM, GSS, GTATQ, GTE, HAL, HAR, HBM, HCLP, HEP, HERO, HES, HFC, HIG, HK, HL, HLF, HLX, HMA, HON, HOS, HP, HPQ, HPT, HRS, HRZN, HTA, HTGC, HTLF, HURN, HZNP, IACI, IAG, IGTE, INN, INT, INTC, INVN, IO, IP, IPGP, IQNT, IRDM, IRET, IRT, ISRG, ISSI, ITRI, ITT, IVAC, IVAN, JAZZ, JDSU, JEC, JNJ, JNPR, JOY, JPM, KBH, KBR, KCAP, KDN, KEG, KERX, KEYN, KFY, KKR, KLAC, KLIC, KO, KOG, KONA, KR, KRA, KRG, KRO, LAD, LCI, LGCY, LIME, LINE, LLL, LLNW, LLY, LMOS, LMT, LNCO, LNKD, LO, LOCO, LOW, LPRI, LPX, LRE, LSI, LUK, LULU, LVS, LXP, LYB, M, MAN, MANT, MCEP, MCGC, MCHX, MCP, MDR, MDT, MEI, MELI, MEMP, MET, MHR, MIND, MITL, MMLP, MMP, MNK, MO, MOD, MOS, MPC, MPO, MPW, MRCY, MRGE, MRK, MRO, MRVL, MS, MSFT, MT, MTDR, MTOR, MTSN, MTZ, MU, MUR, MXIM, MYL, MYRG, NAVB, NBL, NBR, NCT, NE, NEE, NEM, NEON, NFLX, NFX, NGLS, NIHD, NILE, NOG, NOK, NOV, NPTN, NR, NSC, NSPH, NTAP, NTSP, NUAN, NVAX, NVDA, NVS, NWY, NXPI, NYCB, NYX, OAK, OAS, OCN, OCZ, OHAI, OHI, OI, OIS, OKS, OME, OPLK, ORAN, ORBK, ORCL, ORIG, ORLY, OUTR, OVTI, OXY, OZM, PAA, PAAS, PACD, PACR, PANW, PAYX, PBF, PBH, PBI, PBY, PCLN, PCTI, PDH, PDLI, PDS, PEET, PEG, PES, PETM, PETS, PFE, PFMT, PGEM, PH, PKT, PKY, PLAB, PM, PNC, PNG, PNK, PNRA, POM, POT, PRTA, PRU, PSX, PTEN, PTX, PULB, PVR, PWER, QCCO, QCOM, QLGC, QLTY, QRE, QRVO, QSR, QUMU, R, RAIL, RAX, RCL, RDC, RDWR, REGN, RES, REXX, RF, RHI, RHT, RIG, RIGL, RIO, RNET, RNN, ROC, ROSE, ROVI, RPRX, RPTP, RRD, RSTI, RTEC, RTN, RUE, RUTH, RVBD, SAM, SARA, SBRA, SCLN, SCMR, SD, SDRL, SEAC, SFY, SGY, SHOR, SIGA, SIMG, SIMO, SIRI, SKUL, SLB, SLCA, SLTM, SLW, SM, SMCI, SN, SNH, SNY, SODA, SPLK, SPLS, SPN, SPPI, SPRT, SPY, SQNM, SSH, SSNLF, STI, STJ, STKL, STMP, STO, STT, STX, SUNE, SVU, SWFT, SWKS, SYMC, SYNA, SYPR, SYRG, SYY, T, TAL, TAP, TBT, TC, TCAP, TDW, TEF, TER, TESO, TEVA, TEX, TGX, TICC, TIVO, TKR, TLLP, TLM, TMO, TOT, TPC, TPLM, TRLG, TRN, TRP, TSLA, TSO, TST, TSYS, TTI, TWC, TWI, TWO, TWX, UA, UNH, UNIS, UNT, UPL, URI, USB, V, VALE, VELTF, VICL, VLO, VMW, VNR, VOD, VRA, VSEC, VXX, VZ, WAC, WBA, WDC, WEN, WFC, WFT, WHR, WIFI, WLL, WMT, WRES, XEC, XOM, XRX, YELP, YHOO, Z, ZAGG, ZEUS, ZIXI, ZLTQ, ZNGA
  • Gilead: Catalysts In Place For A Big October
    Oct. 6, 2014 GILD 122 Comments

    Summary

    • The stock of Gilead Sciences has been stuck in a relatively tight trading range over the past six weeks and is consolidating some major gains in 2014.
    • However, the company has several major catalysts that could significantly buoy the shares significantly in October.
    • Those catalysts and why I could see the shares hitting $120 a share over the next month are profiled below.
  • Micron: Barron's Sees $50 A Share In The Cards
    Oct. 5, 2014 MU 52 Comments

    Summary

    • Micron Technologies is a misunderstand stock whose business fundamentals have improved as its core DRAM market has consolidated down to three major manufacturers.
    • This week Barron's provides a solid spotlight piece on Micron that postulates the shares could soon hit $50, some 50% upside from its current price.
    • I hold and have written about the stock over the summer as I believe the shares are cheap and have considerable upside. The bull investment thesis is presented below.
  • Digging Through The Carnage In The Energy Sector
    Oct. 4, 2014 CHK, COP, EXXI 70 Comments

    Summary

    • The energy sector has been hit hard by plunging oil and natural gas prices over the past few months.
    • Larger E&P names have shed 10% to 20% of their value. Many smaller concerns are down 30% to 50% since the beginning of third quarter.
    • There are some excellent long term buying opportunities for patient investors. Here is how I am playing the downturn within my own portfolio.
  • It's Time To Consider ConocoPhillips Again
    Oct. 3, 2014 COP 95 Comments

    Summary

    • The stock of ConocoPhillips has declined more than 15% in recent months as falling oil & natural gas prices has hammered the entire E&P sector.
    • The decline has caused the stock to approach a four percent dividend yield; a level it has bounced off of in the past.
    • I think the recent pullback makes ConocoPhillips an actionable investment idea for value and dividend investors. The stock should have more than 15% upside over the coming year.
  • Yes Virginia, The Market Can Go Down - Part II
    Oct. 2, 2014 M, MU, DIA 42 Comments

    Summary

    • As I predicted when it happened, the 2,000 level on the S&P 500 has proven to be a very stubborn resistance level for the market to breach decisively.
    • The recent downturn in the market has accelerated recently due to some of the concerns I highlighted for investors in another column.
    • These worries could remain for a while and the market started the fourth quarter with a thud. What I see ahead and how I am playing the market given these concerns.
  • Energy EXXI: A Major Opportunity For Patient Investors
    Oct. 1, 2014 EXXI 82 Comments

    Summary

    • Exploration & Production stocks suffered significant declines in the recently completed third quarter on the back of falling oil & natural gas prices. The offshore space was hit particularly hard.
    • I have been adding new names and additional shares to existing stakes in this sector recently as valuations have become attractive and energy prices should firm as winter approaches.
    • Today I am profiling an offshore play that has been cut in half recently on a big acquisition and negative sentiment on the sector.
    • This shares are selling for less than half the median price target held by analysts that cover the company. Read why this is my highest risk/highest reward E&P play currently.
  • Sabra Health Care: High-Yield Play At Attractive Valuations
    Oct. 1, 2014 SBRA 19 Comments

    Summary

    • My regular readers know I use the declines caused by secondary offerings to pick up high-yield real estate investment trusts (REITs) at discounted prices.
    • These secondary offerings can create temporary inefficiencies in pricing that can lead to some easy and profitable trading opportunities, which occur quite often in the market.
    • This week's REIT special is an attractive high-yield play in the healthcare space that is off some 20% from recent highs and trading at a discount to peers.
  • Ford: Groping For A Floor
    Sep. 30, 2014 F 67 Comments

    Summary

    • The shares of Ford have sold off some 10% over the past two days after management announced that profits for 2014 will be lower than originally expected.
    • There are myriad reasons to believe that the stock is near a floor, and patient investors will be rewarded for buying additional shares at this discounted entry level.
    • The shares are cheap, the stock provides a 3% dividend yield and 2015 will bring sunnier skies for this American manufacturing icon.
  • 4 Predictions For The Fourth Quarter
    Sep. 30, 2014 GILD, F, SPY 100 Comments

    Summary

    • It was an interesting third quarter as the market struggled despite better than expected earnings results for the second quarter.
    • Small and midcap stocks suffered losses in the quarter and new worries were adding to investors' growing list of concerns.
    • So as we enter the last day of the third quarter, what lies ahead for equities in the fourth quarter? My four predictions for the next quarter are outlined below.
  • Legacy Reserves: RBC Capital's Top High Yield Upstream Play
    Sep. 29, 2014 LGCY 22 Comments

    Summary

    • RBC Capital made Legacy Reserves their top pick in the oil & gas upstream space on Monday.
    • Legacy has a proven record of production growth through strategic acquisitions that the company integrates efficiently to drive a consistent history of impressive growth.
    • For investors comfortable with the tax complexities of master limited partnerships, Legacy's record of growth and over 8% yield are worth considering.
  • 2 Attractive Small Cap Biotech Stocks With Recent Insider Buying
    Sep. 29, 2014 DVAX, HALO 22 Comments

    Summary

    • The small biotech sector is a tricky and volatile to one to invest in due to the complexities of developing new compounds and getting them through the approval process.
    • Two of the catalysts I look for when making new investments in this space is insider buying and a pipeline that contains several "shots on goal".
    • Below are two small biotech stocks that are down significantly from previous highs, have seen some recent insider buying and have interesting products in development.
  • Profiting From Permian Mergers And Acquisitions Activity Accelerating
    Sep. 29, 2014 CPE, FANG 14 Comments

    Summary

    • There was a major acquisition in the Permian Basin announced this morning. This could be the start of the start of increasing M&A activity in the region.
    • Interest rates remain historically low, the region continues to see impressive production growth and infrastructure is getting built out and improving in this shale play.
    • Two Permian plays are profiled below. Both are attractive based on their current growth prospects. They are also cheap given what Encana just paid for Athlon Energy.
  • The Bull Case For Devon Energy Is Getting Stronger
    Sep. 28, 2014 DVN 32 Comments

    Summary

    • The exploration & production sector has been a significant underperformer in the market during the 3rd quarter due to falling oil & natural gas prices.
    • There are many attractive buying opportunities thanks to the recent decline in front of what is looking to be a cold winter. Devon Energy is one of those opportunities.
    • The company is significantly boosting oil production, the stock is cheap given its growth prospects and the bull case for owning this mid-major is very strong right now.
  • Warren Resources: My First Trade For Monday
    Sep. 28, 2014 WRES 43 Comments

    Summary

    • The small energy exploration and production sector has been hit hard this quarter by falling oil & natural gas prices. Many stocks in the sector are down 15% to 25%.
    • After their recent decline, many of these stocks are offering attractive entry points in front of what is shaping up to be another brutal winter.
    • One of these attractive E&P plays is an old friend to my own portfolio named Warren Resources. Why the shares are undervalued is profiled below.
  • Celgene: Jim Cramer's Favorite Biotech Juggernaut
    Sep. 26, 2014 CELG 32 Comments

    Summary

    • Today we will take a look at Celgene, one of the "Big Four" of biotech, and Jim Cramer's current favorite large biotech concern.
    • The company has one of the deepest pipelines in biotech and has years of stellar growth ahead of it.
    • Some of these drugs are highlighted in this article. Why I believe the stock has better than 80% upside over the next three years is highlighted below as well.
  • Micron: Now Poised To Break Out
    Sep. 26, 2014 MU 27 Comments

    Summary

    • Micron Technology has been stuck in a relatively narrow trading range over the prior three months as the equity has become a battleground stock between bulls and bears.
    • I have been firmly planted in the Bull Camp. Quarterly earnings results confirmed that view and removed a major headwind to the next leg of the rally in the stock.
    • The shares are cheap and the company has solid growth prospects. Why the shares are going higher is profiled below.
  • Yes Virginia, The Market Can Go Down - Part I
    Sep. 25, 2014 SPY, IWM, UUP 47 Comments

    Summary

    • The recent market decline is accelerating through midday trading Thursday. This is something I have been cautioning investors against throughout September.
    • There are myriad warning signs that are foreshadowing further declines that should be watch items for equity investors as I believe they will drive market direction over the coming months.
    • What I am watching in the market right now and how I am positioning my own portfolio during this recent uptick in volatility is detailed below.
  • Gilead: Could Japan Power Next Major Leg Of The Rally?
    Sep. 24, 2014 GILD 41 Comments

    Summary

    • The stock of Gilead Sciences has spent the last month in a consolidation phase. However, the company has received several catalysts recently that should power the next leg of rally.
    • These include two major markets on the verge of being able to distribute its blockbuster drug Sovaldi, a major analyst upgrade and positive Phase III trial results.
    • Despite the huge gains in the stock over the past year, the shares are still cheap compared to the market. Why the shares could power higher by 40% is profiled below.
  • Chesapeake Energy: Barron's Thinks Earnings Can Double Over Next Few Years
    Sep. 24, 2014 CHK 18 Comments

    Summary

    • I have been reading Barron's for thirty years and the magazine consistently provides a good flow of starting points for possible new investments.
    • This week's magazine has a couple of positive paragraphs on the investment case for owning Chesapeake Energy. An opinion I share as I recently purchased the stock.
    • This energy producer's stock is cheap compared with peers, the company is set to make dramatic operational improvements and earnings could more than double over the next four years.
  • Are Investors Positioned For An October Surprise?
    Sep. 23, 2014 SPY, DIA, IWM 55 Comments

    Summary

    • Equities continue to be unable to break above 2,000 on the S&P 500 in a decisive manner. Both the S&P and DJIA had their worst day in a month Monday.
    • Some cracks are starting to develop in the market as we head into October, a month that has historically seen some major sell-offs in equities over the decades.
    • Investors should have some "watch items" on their list over the next month. Why I believe a cautious portfolio stance is warranted at the present time is profiled below.
  • Why DiamondRock Hospitality Remains A Core Part Of My Income Portfolio
    Sep. 22, 2014 DRH 4 Comments

    Summary

    • I have been lightening my allocation to high-yield sectors such as REITs and energy partnerships since the conclusion of the first half of 2014.
    • This is prudent given interest rates should rise from here and valuations are less attractive than a year ago. One exception is lodging REITs given improving fundamentals in the sector.
    • DiamondRock Hospitality has provided over 40% returns, including dividends, since I last did a deep dive on it in June 2013. Why I see further upside ahead is profiled below.
  • Apple: Still Some Mojo And Upside Left
    Sep. 22, 2014 AAPL 57 Comments

    Summary

    • The stock of Apple is up some 75% since it supposedly lost its "mojo" in 2013. Ironically, it is Apple's competitors in the smartphone space that have been under distress.
    • The tech giant from Cupertino is starting to hit on all cylinders, and has solid growth prospects ahead of it.
    • The stock will not deliver the same returns to shareholders over the next year. However, 15% to 20% upside over the next 12 months seems like a reasonable expectation.
  • Barron's And Goldman Sachs Say Buy Bank Of America
    Sep. 21, 2014 BAC 103 Comments

    Summary

    • The sentiment on Bank of America has grown increasingly positive since it settled mortgage litigation with the federal government.
    • Recently Goldman Sachs and Barron's have chimed in on how the bank's underlying business fundamentals are improving and why the shares are undervalued.
    • I believe the recent uptrend in the stock will continue for myriad reasons. Why I think the shares hit $25 a share over the next two years is profiled below.
  • Yahoo: An Easy Way To Profit From Alibaba
    Sep. 20, 2014 YHOO 91 Comments

    Summary

    • The talk of the street this week was the massive IPO of the Chinese retailer Alibaba which had myriad impacts on the overall market as well.
    • Yahoo unjustifiably declined on Friday and I picked up some long exposure as the stock looks to have little downside from here.
    • Why I think Yahoo is undervalued here given its remaining stake in Alibaba as well as two ways to play this undervaluation.
  • Finding Small Cap Gems Within Biotech
    Sep. 19, 2014 PRTA 42 Comments

    Summary

    • I have received numerous inquiries from readers recently on how I identify potential winners in the small cap biotech, medical device and pharma sectors due to some recent major successes.
    • There are many traits I look for when researching possible purchases. They include strong management teams, solid balance sheets, deep pipelines and potential lucrative positive catalysts.
    • Prothena Corporation is an example of the type of small cap equity that meets the criteria for inclusion into my "shotgun investing" biotech portfolio and is profiled below.
  • Gilead: Still 50% Upside Left In The Stock
    Sep. 18, 2014 GILD 86 Comments

    Summary

    • After rocketing up after a brief downdraft that hit all biotech stocks in early March, Gilead Sciences has been stuck in a trading range over the last month.
    • This has inspired some concerns by investors in this biotech juggernaut. These worries will soon dissipate and the stock should take the next leg higher.
    • Why the shares are still extremely cheap after their stellar performance in 2014 and have 50% upside by the end of 2015 is profiled below.
  • My Contrarian Play On Housing Is Starting To Pay Off
    Sep. 17, 2014 BZH, LEN, TPH 15 Comments

    Summary

    • My contrarian view on homebuilding stocks is starting to play out as major homebuilders are starting to report much better than expected results.
    • In addition, Homebuilder confidence is at its highest levels since late in 2005. These data points are boosting homebuilding stocks considerably in trading today.
    • I believe we are in the early innings of a big move in this sector for myriad reasons. Highlighted below is how I am playing this contrarian thesis.
  • Watching The Elections In Brazil Not Scotland
    Sep. 17, 2014 PBR, VALE, EWZ 26 Comments

    Summary

    • Investors' eyes are focused on the outcome of the upcoming election in Scotland. Being in Miami, mine are turned on the unfolding election drama down south in Brazil.
    • The election of a pro-business outsider could have major ramifications for the Brazilian stock market which has vastly underperformed world equity markets for years.
    • Profiled below is how I am playing a possible "regime" change down south and why I think this is an actionable investment event.
  • 2 Small Exploration And Production Plays Being Bolstered By Upward Production Guidance
    Sep. 16, 2014 AXAS, REXX 20 Comments

    Summary

    • The E&P sector has been under pressure over the summer due primarily to falling oil and natural gas prices.
    • I have been adding to some of my smaller plays in the space as they are attractively valued, have fast rising production and should do well during the upcoming winter.
    • Two of these companies are profiled below. Both firms recently upped their production guidance and today's rallies in their stocks should continue.
  • The Time For Caution Has Arrived
    Sep. 16, 2014 DIA, SPY, QQQ 121 Comments

    Summary

    • The S&P 500 at the 2,000 level is looking like a strong resistance point for the market and we are starting to see divergence in equities.
    • "Risk On" sectors and stocks are behaving very poorly at the moment and there are several other factors that merit a cautious stance at these levels.
    • These factors are highlighted below in addition to how I am positioning my portfolio in advance of what I think will be greater volatility in the months ahead.
  • Apple: The Way Now Open To $120
    Sep. 15, 2014 AAPL 88 Comments

    Summary

    • The unveiling of the Apple Watch, Apple Pay and the new versions of the iconic iPhone franchise garnered much press last week during and after the big "reveal".
    • Apple stockholders can now return to normalcy and concentrate on the core trends that will continue to generate shareholder value.
    • Despite an over 75% run over the past five quarters, the shares are still cheap compared to the market. Why I believe they will hit $120 over the next year.
  • Could Alibaba's IPO Suck The Life From Amazon?
    Sep. 14, 2014 AMZN 57 Comments

    Summary

    • The big story next week in the market is the upcoming massive Initial Public Offering of Chinese online retailing giant Alibaba.
    • This offering has already started to have impact on a couple of large U.S. based online stocks and these could grow next week when Alibaba debuts.
    • The stock of Amazon looks very vulnerable to a much deeper decline due to myriad reasons and should be avoided by investors at these levels.